At the last check on Friday, Dolby Laboratories Inc.’s (NYSE:DLB) stock was up $7.75, moving up 10.09 percent to $84.57. The average number of shares traded per day over the past five days has been 547,265 shares. 3 times new highs have been achieved over the past 5 days, with a $8.01 gain in that time frame. In the last twenty days, the average volume was 424,516, while in the previous 50 days, it was 359,857.
Since last month, DLB stock retreated -4.84%. Shares of the company fell to $75.87 on 08/16/23, the lowest level in the past month. A 52-week high of $91.01 was reached on 07/13/23 after having rallying from a 52-week low of $61.55. Since the beginning of this year, DLB’s stock price has risen by 19.89% or $14.16, and marked a new high 15 times. However, the stock has declined by -7.08% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
DLB stock investors should be aware that Dolby Laboratories Inc. (DLB) stock had its last reported insider trading activity 36 days ago on Jul 13. YEAMAN KEVIN J, the President and CEO of the company, disposed of 27,090 shares for $90.00 on Jul 13. It resulted in a $2,438,100 divestment by the insider. SHERMAN MARK ANDREW sold 21,000 shares at an average price of $89.00 on Jul 12. The insider now owns 56,730 shares following the transaction. On Jul 11, President and CEO YEAMAN KEVIN J sold 18,060 shares at $87.83 apiece. The transaction was valued at $1,586,295.
Valuation Metrics
Right now, Dolby Laboratories Inc. (DLB) has a P/E ratio of about 37.59. The stock’s beta is 1.01. Besides these, the trailing price-to-sales (P/S) ratio of 6.30, the price-to-book (PB) ratio of 3.42, and the price-to-cash flow ratio of 26.99 may also be considered.
The latest dividend of $0.27 per share was paid out, remained unchanged from last year’s $0.27. On Thursday November 17 2022, a $0.02 dividend increase was announced.
Financial Health
In the three months ended June 29, Dolby Laboratories Inc.’s quick ratio stood at 3.40, while its current ratio was 3.50, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 88.00% percent. In the year ended June 29, EBITDA margin amounted to 25.59%, whereas operating margins totaled 19.10%. Based on annual data, DLB earned $1.11 billion in gross profit and brought in $1.25 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 7.80%. Return on equity (ROE) for the past 12 months was 9.50%.
According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. DLB’s revenue rose 2.94% to $375.89 million during the quarter, while net income inched up to $298.37 million. While analysts expected Dolby Laboratories Inc. to report $0.55 quarterly earnings, the actual figure was $0.55 per share. During the quarter, the company generated $40.02 million in EBITDA. The liabilities of Dolby Laboratories Inc. were 625.22 million at the end of its most recent quarter ended June 29, and its total debt was $50.06 million. The value of shareholders’ equity is $95.64 million.
Technical Picture
This quick technical analysis looks at Dolby Laboratories Inc.’s (DLB) price momentum. With a historical volatility rate of 52.63%, the RSI 9-day stood at 62.93% on 17 August.
With respect to its five-day moving average, the current Dolby Laboratories Inc. price is up by +10.44% percent or $8.01. At present, DLB shares trade -4.62% below its 20-day simple moving average and +1.51% percent above its 100-day simple moving average. However, the stock is currently trading approximately +2.11% above its SMA50 and +26.72% above its SMA200.
Stochastic coefficient K was 24.91% and Stochastic coefficient D was 12.67%, while ATR was 2.40. Given the Stochastic reading of 65.99% for the 14-day period, the RSI (14) reading has been calculated as 56.22%. As of today, the MACD Oscillator reading stands at 1.31, while the 14-day reading stands at -1.07.
Analyst Ratings
Dolby Laboratories Inc. downgraded its rating on Dolby Laboratories Inc. (NYSE: DLB) to a Mkt perform in a note to investors on November 18, 2022. The analysts firm previously had an Outperform rating on the stock.Dolby Laboratories Inc. (DLB) has been rated Overweight by analysts. According to 0 brokerage firms, DLB is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Dolby Laboratories Inc. stock as buy, with 2 recommending it as overweight.
With a median target price of $98.00, the current consensus forecast for the stock is $98.00 – $98.00. Based on these forecasts, analysts predict Dolby Laboratories Inc. (DLB) will achieve an average price target of $98.00.
